OP-135 Relationship Between Serum Galectin-3 Levels and Atrial Electromechanical Delay in Patients with Paroxysmal Atrial Fibrillation




Objectives


Left atrial (LA) interstitial fibrosis is known to have a role in the initiation and maintenance of atrial fibrillation (AF). Although the role of galectin-3 in the pathogenesis of cardiac fibrosis has been demonstrated before in heart failure patients, link between galectin-3 and atrial fibrosis is still not clear. Atrial electromechanical delay (AEMD) is a non-invasive echocardiographic method to evaluate atrial remodeling. We aimed to determine whether serum galectin-3 level correlated with AEMD in paroxysmal AF patients with preserved left ventricular function.




Methods


Paroxysmal AF patients with preserved left ventricular function were included in the study. Serum galectin-3 levels were measured with ELISA. Transthoracic echocardiography was performed to evaluate AEMD.

Only gold members can continue reading. Log In or Register to continue

Related posts:

  1. OP-001 An Under-estimated Complication ff Atrial Fibrillation Ablation: Gastroparesis
  2. OP-038 Reduction of Eosinophil Percentage may Predict the Mortality from Acute Coronary Syndromes
  3. OP-065 Increased Platelet-to-Lymphocyte Ratio is Related to Slow Coronary Flow
  4. OP-100 Pulmonary Function after Transcatheter Aortic Valve Implantation in Patients with High Risk Aortic Stenosis

Stay updated, free articles. Join our Telegram channel
Tags:
Nov 30, 2016 | Posted by in CARDIOLOGY | Comments Off on OP-135 Relationship Between Serum Galectin-3 Levels and Atrial Electromechanical Delay in Patients with Paroxysmal Atrial Fibrillation

Full access? Get Clinical Tree
Get Clinical Tree app for offline access